Literature DB >> 10615943

Portal vein afferents are critical for the sympathoadrenal response to hypoglycemia.

A L Hevener1, R N Bergman, C M Donovan.   

Abstract

We sought to elucidate the role of the portal vein afferents in the sympathetic response to hypoglycemia. Laparotomy was performed on 27 male Wistar rats. Portal veins were painted with either 90% phenol (denervation group [PDN]) or 0.9% saline solution (sham-operated group [SHAM]). Rats were chronically cannulated in the carotid artery (sampling), jugular vein (infusion), and portal vein (infusion). After a recovery period of 5 days, animals were exposed to a hyperinsulinemic-hypoglycemic clamp, with glucose infused either portally (POR) or peripherally (PER). In all animals, systemic hypoglycemia (2.48+/-0.09 mmol/l) was induced via jugular vein insulin infusion (50 mU x kg(-1) x min(-1)). Arterial plasma catecholamines were assessed at basal (-30 and 0 min) and during sustained hypoglycemia (60, 75, 90, and 105 min). By design, portal vein glucose concentrations were significantly elevated during POR versus PER (4.4+/-0.14 vs. 2.5+/-0.07 mmol/l; P<0.01, respectively) for both PDN and SHAM. There were no significant differences in arterial glucose or insulin concentration between the four experimental conditions at any point in time. When portal glycemia and systemic glycemia fell concomitantly (SHAM-PER), epinephrine increased 12-fold above basal (3.75+/-0.34 and 44.56+/-6.1 nmol/l; P<0.001). However, maintenance of portal normoglycemia (SHAM-POR) caused a 50% suppression of the epinephrine response, despite cerebral hypoglycemia (22.2+/-3.1 nmol/l, P<0.001). Portal denervation resulted in a significant blunting of the sympathoadrenal response to whole-body hypoglycemia (PDN-PER 27.6+/-3.8 nmol/l vs. SHAM-PER; P<0.002). In contrast to the sham experiments, there was no further suppression in arterial epinephrine concentrations observed during PDN-POR versus PDN-PER (P = 0.8). These findings indicate that portal vein afferent innervation is critical for hypoglycemic detection and normal sympathoadrenal counterregulation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10615943     DOI: 10.2337/diabetes.49.1.8

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  26 in total

1.  Rate of fall in blood glucose and recurrent hypoglycemia affect glucose dynamics and noradrenergic activation in the ventromedial hypothalamus.

Authors:  Meredith B Barnes; Marcus A Lawson; J Lee Beverly
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-09-28       Impact factor: 3.619

Review 2.  Neuroendocrine responses to hypoglycemia.

Authors:  Nolawit Tesfaye; Elizabeth R Seaquist
Journal:  Ann N Y Acad Sci       Date:  2010-10-29       Impact factor: 5.691

3.  Regulation of glucagon secretion by glucose transporter type 2 (glut2) and astrocyte-dependent glucose sensors.

Authors:  Nell Marty; Michel Dallaporta; Marc Foretz; Martine Emery; David Tarussio; Isabelle Bady; Christophe Binnert; Friedrich Beermann; Bernard Thorens
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

4.  Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage.

Authors:  Claude Knauf; Patrice D Cani; Christophe Perrin; Miguel A Iglesias; Jean François Maury; Elodie Bernard; Fadilha Benhamed; Thierry Grémeaux; Daniel J Drucker; C Ronald Kahn; Jean Girard; Jean François Tanti; Nathalie M Delzenne; Catherine Postic; Rémy Burcelin
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

5.  Adrenaline is a critical mediator of acute exercise-induced AMP-activated protein kinase activation in adipocytes.

Authors:  Ho-Jin Koh; Michael F Hirshman; Huamei He; Yangfeng Li; Yasuko Manabe; James A Balschi; Laurie J Goodyear
Journal:  Biochem J       Date:  2007-05-01       Impact factor: 3.857

Review 6.  Multiple hypothalamic circuits sense and regulate glucose levels.

Authors:  Mahesh Karnani; Denis Burdakov
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-11-03       Impact factor: 3.619

7.  Synergistic effect of portal glucose and glucagon-like peptide-1 to lower systemic glucose and stimulate counter-regulatory hormones.

Authors:  V Ionut; K Hucking; I F Liberty; R N Bergman
Journal:  Diabetologia       Date:  2005-04-14       Impact factor: 10.122

Review 8.  Peripheral and central glucose sensing in hypoglycemic detection.

Authors:  Casey M Donovan; Alan G Watts
Journal:  Physiology (Bethesda)       Date:  2014-09

Review 9.  Sweet talk in the brain: glucosensing, neural networks, and hypoglycemic counterregulation.

Authors:  Alan G Watts; Casey M Donovan
Journal:  Front Neuroendocrinol       Date:  2009-10-24       Impact factor: 8.606

10.  Essentiality of portal vein receptors in hypoglycemic counterregulation: direct proof via denervation in male canines.

Authors:  Viorica Ionut; Ana Valeria B Castro; Orison O Woolcott; Darko Stefanovski; Malini S Iyer; Josiane L Broussard; Hasmik Mkrtchyan; Miguel Burch; Ram Elazary; Erlinda Kirkman; Richard N Bergman
Journal:  Endocrinology       Date:  2014-01-15       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.